A robust RNA-seq preprocessing workflow is the critical foundation for all downstream transcriptomic analyses, directly impacting the accuracy and reproducibility of biological insights.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for understanding, managing, and mitigating technical variation in RNA-seq studies.
This article provides a comprehensive guide for researchers and drug development professionals on filtering low-quality cells in single-cell RNA sequencing (scRNA-seq) data.
This article provides a comprehensive framework for interpreting and handling high mitochondrial RNA content in single-cell RNA-sequencing data, moving beyond traditional filtering approaches.
Low mapping rates in RNA-seq data represent a critical bottleneck that compromises gene expression analysis, biomarker discovery, and therapeutic development.
GC bias, the dependence of sequencing read coverage on guanine-cytosine content, is a major technical artifact that confounds transcriptomics analysis, leading to inaccurate gene expression quantification and differential expression results.
This article provides a complete framework for researchers and drug development professionals to optimize RNA integrity for sequencing applications.
This guide provides a comprehensive framework for researchers and drug development professionals to diagnose, troubleshoot, and resolve common and complex issues in RNA-seq data.
Outlier detection in RNA-Seq data is a critical quality control and discovery step for researchers in genomics and drug development.
This article provides a comprehensive roadmap for researchers and drug development professionals navigating the complex landscape of multi-omics data integration.